Belimumab (Benlysta) Cleared in Japan for Lupus

Share this post

Belimumab is now approved in Japan for the treatment of adults with active, autoantibody-positive systemic lupus erythematosus who do not respond adequately to existing therapies.
International Approvals

This post was syndicated from Medscape Medical News Headlines. Click here to read the full text on the original website.


Share this post

Be the first to comment

Leave a Reply